176 related articles for article (PubMed ID: 23727122)
41. Screening of circulating TGF-β levels and its clinicopathological significance in human breast cancer.
Panis C; Herrera AC; Victorino VJ; Aranome AM; Cecchini R
Anticancer Res; 2013 Feb; 33(2):737-42. PubMed ID: 23393376
[TBL] [Abstract][Full Text] [Related]
42. Serum transforming growth factor-beta1 levels and pancreatic cancer risk: a nested case-control study (Japan).
Lin Y; Kikuchi S; Tamakoshi A; Obata Y; Yagyu K; Inaba Y; Kurosawa M; Kawamura T; Motohashi Y; Ishibashi T;
Cancer Causes Control; 2006 Oct; 17(8):1077-82. PubMed ID: 16933058
[TBL] [Abstract][Full Text] [Related]
43. Serum levels of transforming growth factor alpha in gastrointestinal cancer patients.
Moskal TL; Huang S; Ellis LM; Fritsche HA; Chakrabarty S
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):127-31. PubMed ID: 7742720
[TBL] [Abstract][Full Text] [Related]
44. Serum levels of angiogenic factors in early breast cancer remain close to normal.
Duranyildiz D; Camlica H; Soydinc HO; Derin D; Yasasever V
Breast; 2009 Feb; 18(1):26-9. PubMed ID: 18996696
[TBL] [Abstract][Full Text] [Related]
45. Serum angiopoietin-1 as a prognostic marker in resected early stage lung cancer.
Park JH; Choi H; Kim YB; Kim YS; Sheen SS; Choi JH; Lee HL; Lee KS; Chung WY; Lee S; Park KJ; Hwang SC; Lee KB; Park KJ
Lung Cancer; 2009 Dec; 66(3):359-64. PubMed ID: 19339077
[TBL] [Abstract][Full Text] [Related]
46. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1.
Hirschberg A; Jókúti A; Darvas Z; Almay K; Répássy G; Falus A
Laryngoscope; 2003 Jan; 113(1):120-4. PubMed ID: 12514394
[TBL] [Abstract][Full Text] [Related]
47. The alteration of plasma TGF-β1 levels in patients with brain tumors after tumor removal.
Loh JK; Lieu AS; Su YF; Cheng CY; Tsai TH; Lin CL; Lee KS; Hwang SL; Kwan AL; Wang CJ; Hong YR; Howng SL; Chio CC
Kaohsiung J Med Sci; 2012 Jun; 28(6):316-21. PubMed ID: 22632886
[TBL] [Abstract][Full Text] [Related]
48. Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients.
Novakova-Jiresova A; Van Gameren MM; Coppes RP; Kampinga HH; Groen HJ
Radiother Oncol; 2004 May; 71(2):183-9. PubMed ID: 15110452
[TBL] [Abstract][Full Text] [Related]
49. Combined assessment of TGF-beta-1 and alpha-fetoprotein values improves specificity in the diagnosis of hepatocellular carcinoma and other chronic liver diseases in Malaysia.
Yasmin Anum MY; Looi ML; Nor Aini AH; Merican I; Wahidah A; Mohd Radzi AH; Nor Azizah A; Othman NH
Med J Malaysia; 2009 Sep; 64(3):223-7. PubMed ID: 20527273
[TBL] [Abstract][Full Text] [Related]
50. Prospective study of urinary and serum cross-linked N-telopeptide of type I collagen (NTx) for diagnosis of bone metastasis in patients with lung cancer.
Tamiya M; Tokunaga S; Okada H; Suzuki H; Kobayashi M; Sasada S; Okamoto N; Morishita N; Matsuura Y; Miyamoto N; Hattori M; Taira K; Daga H; Takeda K; Hirashima T
Clin Lung Cancer; 2013 Jul; 14(4):364-9. PubMed ID: 23276824
[TBL] [Abstract][Full Text] [Related]
51. Transforming growth factor beta as a clinical biomarker for prostate cancer.
Perry KT; Anthony CT; Case T; Steiner MS
Urology; 1997 Jan; 49(1):151-5. PubMed ID: 9000208
[TBL] [Abstract][Full Text] [Related]
52. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.
Tas F; Yasasever CT; Karabulut S; Tastekin D; Duranyildiz D
Tumour Biol; 2015 Mar; 36(3):2097-103. PubMed ID: 25391430
[TBL] [Abstract][Full Text] [Related]
53. Circulating TGF-β1 and VEGF and risk of cancer among liver transplant recipients.
Engels EA; Jennings L; Kemp TJ; Chaturvedi AK; Pinto LA; Pfeiffer RM; Trotter JF; Acker M; Onaca N; Klintmalm GB
Cancer Med; 2015 Aug; 4(8):1252-7. PubMed ID: 25919050
[TBL] [Abstract][Full Text] [Related]
54. Transforming growth factor-β1 rise in pleural fluid after tunneled pleural catheter placement: pilot study.
Shojaee S; Voelkel N; Farkas L; de Wit M; Lee HJ
J Bronchology Interv Pulmonol; 2013 Oct; 20(4):304-8. PubMed ID: 24162112
[TBL] [Abstract][Full Text] [Related]
55. The serum level of transforming growth factor beta1 and its association with Foxp3 gene polymorphism in Iranian women with recurrent spontaneous abortion.
Hadinedoushan H; Abbasirad N; Aflatoonian A; Eslami G
Hum Fertil (Camb); 2015 Mar; 18(1):54-9. PubMed ID: 25019584
[TBL] [Abstract][Full Text] [Related]
56. Predictive value of transforming growth factor-β1in Chagas disease: towards a biomarker surrogate of clinical outcome.
Saraiva RM; Waghabi MC; Vilela MF; Madeira FS; Sperandio da Silva GM; Xavier SS; Feige JJ; Hasslocher-Moreno AM; Araujo-Jorge TC
Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):518-25. PubMed ID: 23787193
[TBL] [Abstract][Full Text] [Related]
57. Serum levels of transforming growth factor beta1 in patients with breast cancer.
Sheen-Chen SM; Chen HS; Sheen CW; Eng HL; Chen WJ
Arch Surg; 2001 Aug; 136(8):937-40. PubMed ID: 11485532
[TBL] [Abstract][Full Text] [Related]
58. Relationship of serum levels of VEGF and TGF-β1 with radiosensitivity of elderly patients with unresectable non-small cell lung cancer.
Fu ZZ; Gu T; Fu BH; Hua HX; Yang S; Zhang YQ; Gao LM; Li P
Tumour Biol; 2014 May; 35(5):4785-9. PubMed ID: 24557540
[TBL] [Abstract][Full Text] [Related]
59. Reassessing the Role of the Active TGF-
Dantas AT; Gonçalves SM; de Almeida AR; Gonçalves RS; Sampaio MC; Vilar KM; Pereira MC; Rêgo MJ; Pitta ID; Marques CD; Duarte AL; Pitta MG
Dis Markers; 2016; 2016():6064830. PubMed ID: 27965520
[No Abstract] [Full Text] [Related]
60. Transforming Growth Factor Beta 1 (TGF-β1) in Thyroid Cancer Patients: a View from the Peripheral Blood.
Zivancevic-Simonovic S; Mihaljevic O; Mihajlovic D; Milosevic-Djordjevic O; Jovanovic Z; Mijatovic-Teodorovic L; Colic M
Ann Clin Lab Sci; 2016 Jul; 46(4):401-6. PubMed ID: 27466300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
